Greenbrook TMS (GBNHF) Stock Price, News & Analysis

Company Overview

Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared neurostimulation therapy for the treatment of major depressive disorder and other mental health disorders. The company also offers Spravato, an esketamine nasal spray; and other treatment modalities for the treatment of depression and related psychiatric services. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: $0.01 to $0.0134
• 50-Day Range: $0.0099 to $0.0191
• 52-Week Range: $0.01 to $0.64
• Volume: 4,231 shs
• Average Volume: 30,698 shs
• Market Capitalization: $408 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 9/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Miscellaneous health & allied services, not elsewhere classified
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:GBNHF
• CIK: 1735948
• Web: www.greenbrooktms.com
• Phone: 416-322-9700
• Fax: N/A
• Employees: 430
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($1.23)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$48.91 million
• Net Margins: -70.28%
• Pretax Margin: -71.28%
• Return on Equity: N/A
• Return on Assets: -98.87%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.64
• Quick Ratio: 0.64

Sales & Book Value

• Annual Sales: $73.79 million
• Price / Sales: 0.01
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($2.47) per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 40,800,000
• Free Float: 31,959,000
• Market Cap: $408 thousand
• Optionable: N/A
• Beta: 1.28